XM does not provide services to residents of the United States of America.

UK Stocks-Factors to watch on Oct 1



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UK Stocks-Factors to watch on Oct 1</title></head><body>

Oct 1 (Reuters) -Britain's FTSE 100 .FTSE index is seen opening higher, with futures FFIc1 up 0.34%


* HALEON: Pfizer's PFE.N stake sale in British consumer healthcare company Haleon HLN.L has been upsized by 100 million shares to 640 million shares worth about $3.25 billion with strong demand from investors, a bookrunner familiar with the offering said on Monday.

* UNILEVER: Unilever ULVR.L is working on sustainability deals with its top 10 retail customers, including Walmart WMT.N, aimed at cutting greenhouse gas emissions and minimising waste in its supply chain, the consumer giant's CEO said on Monday.

* BABY FORMULA: A Missouri mother and her lawyers this week will aim to convince a jury that Abbott ABT.N, Reckitt's RKT.L Mead Johnson and St. Louis Children's Hospital are responsible for a severe intestinal illness that she says her premature son got from the companies' formulas after he was born at the hospital.

* OIL: Oil prices were flat on Tuesday as stronger supply prospects and tepid global demand growth outweighed worries that escalating tensions in the Middle East could impact output from the key exporting region.

* GOLD: Gold prices were hovering below recent record peaks on Tuesday after the U.S. Federal Reserve chair tempered expectations for more substantial interest rate cuts this year, with investors looking forward to a series of labour data this week for further insights.

* UK's FTSE 100 ended lower on Monday amid broader market weakness, though it clocked quarterly gains, while the midcap index slipped after Aston Martin issued a profit warning.


* UK CORPORATE DIARY:

Greggs

GRG.L

HY results


* For more on the factors affecting European stocks, please click on: LIVE/

TODAY'S UK PAPERS
> Financial Times PRESS/FT
> Other business headlines PRESS/GB



Reporting by Yamini Kalia in Bengaluru

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.